Exploring cell-based tolerance strategies for hand and face transplantation

Area of Science:

• Immunology
• Transplantation Surgery
• Regenerative Medicine

Background:

• Lifelong immunosuppression is a major barrier to the clinical use of reconstructive hand and face transplantation.
• Reducing the need for chronic immunosuppression is crucial for improving patient outcomes and allograft survival.

Purpose of the Study:

• To review cell-based strategies for inducing immune tolerance in reconstructive transplantation.
• To explore how these strategies can mitigate the risks associated with long-term immunosuppression.

Main Methods:

• Review of current clinical and pre-clinical research on cell-based tolerance induction.
• Analysis of strategies including mixed hematopoietic chimerism, regulatory cell therapies (T, B, macrophages, dendritic cells), and mesenchymal stem cells.

Main Results:

• Cell-based approaches show promise in preclinical and clinical models for inducing tolerance.
• Hand and face transplants possess unique features, such as intragraft bone, that support cell-based tolerance induction.

Conclusions:

• Cell-based tolerance induction strategies offer a potential solution to reduce or eliminate the need for lifelong immunosuppression in reconstructive transplantation.
• These approaches may significantly improve the risk-benefit profile of life-changing reconstructive procedures.